Compare RHI & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RHI | PLSE |
|---|---|---|
| Founded | 1948 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.6B |
| IPO Year | 1994 | 2015 |
| Metric | RHI | PLSE |
|---|---|---|
| Price | $37.85 | $52.77 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $30.33 | $22.00 |
| AVG Volume (30 Days) | ★ 1.7M | 578.9K |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 8.68% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.40 | N/A |
| Revenue | ★ $5,378,506,000.00 | N/A |
| Revenue This Year | $1.27 | $840.00 |
| Revenue Next Year | $5.95 | $287.54 |
| P/E Ratio | $94.20 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $21.83 | $12.56 |
| 52 Week High | $46.70 | $58.90 |
| Indicator | RHI | PLSE |
|---|---|---|
| Relative Strength Index (RSI) | 32.84 | 67.23 |
| Support Level | $26.19 | $24.27 |
| Resistance Level | $46.36 | N/A |
| Average True Range (ATR) | 1.58 | 3.85 |
| MACD | -1.04 | -0.21 |
| Stochastic Oscillator | 0.33 | 63.42 |
Robert Half Inc was founded in 1948, Robert Half provides temporary, permanent, and outcome-based staffing for both in-person and remote positions in the finance and accounting, technology, legal, marketing, and administrative fields. Its subsidiary consulting arm, Protiviti, specializes in technology, risk, auditing, and compliance matters. The firm generates its sales inside the U.S. and is one of the specialized firms in the fragmented U.S. staffing industry.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.